Generic Drug User Fees Would Fund Faster ANDA Approvals Under FDA Budget
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency’s $2.1 billion FY ’08 budget request also asks for more money for drug safety surveillance and assessment.
You may also be interested in...
FDA To Request Authority To Approve Follow-On Biologics
Agency again seeks user fees to pay for review of generic drug applications and direct-to-consumer TV ads; proposes $984 million budget for human drugs and biologics.
FDA To Request Authority To Approve Follow-On Biologics
Agency again seeks user fees to pay for review of generic drug applications and direct-to-consumer TV ads; proposes $984 million budget for human drugs and biologics.
Pilot Program Will Review First-Year Safety Data for Several NMEs
FDA outlines organizational steps and safety monitoring initiatives in response to IoM report on improving drug safety.